Deep Track Capital, LP
GREENWICH, CT · CIK 1856083 · 13F filing filed 2025-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyGreenwich, CT
$3.1bn
reported value
+0.7% vs Q1 2025
65positions
52.6%in top 10
7 new
18 added
20 reduced
11 sold out
vs Q1 2025
Options: 0 call positions (— notional), 1 put positions ($7.7m notional) – listed below, not included above.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| GUARDANT HEALTH INC GH | $221.2m7.11% | Reduced -1.2m |
| IONIS PHARMACEUTICALS INC IONS | $193.3m6.21% | Added +327.3k |
| PROTAGONIST THERAPEUTICS INC PTGX | $179.4m5.77% | Added +245.9k |
| DYNAVAX TECHNOLOGIES CORP DVAX | $176.5m5.67% | Unchanged |
| INSMED INC INSM | $176.1m5.66% | Added +1.5m |
| AKERO THERAPEUTICS INC AKRO | $162.4m5.22% | Reduced -167.7k |
| IMMUNOVANT INC IMVT | $152.0m4.89% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $132.7m4.26% | Unchanged |
| APELLIS PHARMACEUTICALS INC APLS | $121.2m3.90% | Added +2.0m |
| CYTOKINETICS INC CYTK | $120.6m3.88% | Added +576.1k |
| STRUCTURE THERAPEUTICS INC GPCR | $106.5m3.42% | Added +1.0m |
| 89BIO INC ETNB | $93.3m3.00% | Added +183.7k |
| AXSOME THERAPEUTICS INC AXSM | $83.7m2.69% | New |
| VIRIDIAN THERAPEUTICS INC VRDN | $75.2m2.42% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $70.9m2.28% | Added +265.7k |
| VAXCYTE INC PCVX | $69.9m2.25% | Added +1.4m |
| NURIX THERAPEUTICS INC NRIX | $69.1m2.22% | Added +564.9k |
| GERON CORP GERN | $60.6m1.95% | Added +4.8m |
| IMMUNOCORE HLDGS PLC IMCR | $56.5m1.82% | Added +388.6k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $49.1m1.58% | Unchanged |
| MAZE THERAPEUTICS INC MAZE | $48.5m1.56% | Added +679.8k |
| ANI PHARMACEUTICALS INC ANIP | $45.7m1.47% | Unchanged |
| XENON PHARMACEUTICALS INC XENE | $42.3m1.36% | Added +350.0k |
| DIANTHUS THERAPEUTICS INC DNTH | $41.6m1.34% | Reduced -124.6k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $40.7m1.31% | Unchanged |
| BRIDGEBIO PHARMA INC BBIO | $38.9m1.25% | Reduced -1.9m |
| AUTOLUS THERAPEUTICS PLC AUTL | $38.4m1.24% | Reduced -997.3k |
| METSERA INC COM | $31.1m1.00% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $28.0m0.90% | Added +1.9m |
| TECTONIC THERAPEUTIC INC TECX | $27.9m0.90% | Unchanged |
| ABIVAX SA ABVX | $26.6m0.86% | Reduced -99.1k |
| JADE BIOSCIENCES INC JBIO | $25.1m0.81% | New |
| MBX BIOSCIENCES INC MBX | $25.0m0.80% | Reduced -830.3k |
| COMPASS PATHWAYS PLC CMPS | $24.7m0.79% | Reduced -28.6k |
| GH RESEARCH PLC GHRS | $24.4m0.78% | Unchanged |
| BICARA THERAPEUTICS INC BCAX | $22.5m0.72% | Added +426.7k |
| ORUKA THERAPEUTICS INC ORKA | $21.5m0.69% | Added +474.1k |
| ENGENE HOLDINGS INC COM | $16.6m0.53% | Unchanged |
| MIND MEDICINE MINDMED INC COM NEW | $16.2m0.52% | Unchanged |
| UPSTREAM BIO INC UPB | $15.8m0.51% | Reduced -856.8k |
| OLEMA PHARMACEUTICALS INC OLMA | $14.7m0.47% | Unchanged |
| MERUS N V MRUS | $14.5m0.47% | New |
| CYBIN INC COM NEW | $12.8m0.41% | Unchanged |
| CIDARA THERAPEUTICS INC CDTX | $12.2m0.39% | New |
| BICYCLE THERAPEUTICS PLC BCYC | $8.4m0.27% | Added +436.2k |
| CRESCENT BIOPHARMA INC. CBIO | $7.3m0.24% | New |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $6.6m0.21% | New |
| NOVAVAX INC NVAX | $6.3m0.20% | Reduced -519.6k |
| INVIVYD INC IVVD | $6.1m0.20% | Reduced -1.1m |
| RAPT THERAPEUTICS INC RAPT | $6.0m0.19% | New |
| CONTEXT THERAPEUTICS INC CNTX | $4.9m0.16% | Unchanged |
| PLIANT THERAPEUTICS INC PLRX | $4.6m0.15% | Reduced -1.5m |
| SAREPTA THERAPEUTICS INC SRPT | $4.4m0.14% | Reduced -639.9k |
| XENCOR INC XNCR | $4.3m0.14% | Unchanged |
| INOVIO PHARMACEUTICALS INC INO | $4.0m0.13% | Reduced -1.1m |
| KORRO BIO INC KRRO | $3.5m0.11% | Reduced -596.6k |
| IKENA ONCOLOGY INC COM | $3.4m0.11% | Unchanged |
| SPYRE THERAPEUTICS INC SYRE | $3.3m0.11% | Unchanged |
| ALIGOS THERAPEUTICS INC ALGS | $3.2m0.10% | Unchanged |
| AVALO THERAPEUTICS INC AVTX | $2.8m0.09% | Reduced -292.8k |
| ZURA BIO LTD ZURA | $1.8m0.06% | Reduced -1.6m |
| CLIMB BIO INC CLYM | $1.3m0.04% | Unchanged |
| SEPTERNA INC SEPN | $1.3m0.04% | Reduced -1.8m |
| RAPPORT THERAPEUTICS INC RAPP | $1.1m0.04% | Reduced -359.3k |
| ONKURE THERAPEUTICS INC OKUR | $431.4k0.01% | Reduced -343.5k |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| INTRA-CELLULAR THERAPIES INC ITCI | $263.8m2.0m shares |
| AMGEN INC AMGN | $35.2m113.0k shares |
| EDGEWISE THERAPEUTICS INC EWTX | $30.8m1.4m shares |
| DYNE THERAPEUTICS INC DYN | $20.9m2.0m shares |
| GALAPAGOS NV LKFT | $18.6m741.1k shares |
| SAGE THERAPEUTICS INC SAGE | $16.2m2.0m shares |
| RAPT THERAPEUTICS INC | $7.3m6.0m shares |
| BEAM THERAPEUTICS INC BEAM | $6.2m315.8k shares |
| REGULUS THERAPEUTICS INC RGLS | $5.7m3.3m shares |
| ALLAKOS INC ALLKG | $1.6m7.2m shares |
| NEUROGENE INC NGNE | $1.4m116.7k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SAREPTA THERAPEUTICS INC SRPT · Put | $7.7m450.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 27.
| Company | Stake |
|---|---|
| LB PHARMACEUTICALS INC LBRX · 13D · filed 2026-02-10 | 11.7%≈ $108.8m |
| ALTIMMUNE INC ALT · 13G · filed 2026-04-30 | 10.0%≈ $59.0m |
| PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-06 | 10.0%≈ $11.9m |
| VERASTEM INC VSTM · 13G · filed 2025-11-21 | 10.0%≈ $29.5m |
| COMPASS PATHWAYS PLC CMPS · 13G · filed 2025-01-17 | 10.0% |
| RAPT THERAPEUTICS INC 13G · filed 2024-12-23 | 9.9% |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX · 13G · filed 2026-08-14 | 9.7%≈ $155.7m |
| OCULAR THERAPEUTIX INC OCUL · 13G · filed 2026-05-15 | 9.5%≈ $204.7m |
| MAZE THERAPEUTICS INC MAZE · 13G · filed 2025-08-14 | 9.0%≈ $117.8m |
| IMMUNIC INC 13G · filed 2026-03-04 | 8.7% |
| ALECTOR INC ALEC · 13G · filed 2026-10-23 | 8.6%≈ $21.3m |
| TARSUS PHARMACEUTICALS INC TARS · 13G · filed 2026-05-15 | 8.5%≈ $226.6m |
| X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 | 8.3%≈ $37.6m |
| CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2025-05-15 | 8.3%≈ $4.1m |
| HEMAB THERAPEUTICS HLDGS INC COAG · 13G · filed 2026-05-08 | 8.2%≈ $132.3m |
| CORMEDIX INC CRMD · 13G · filed 2026-05-15 | 7.9%≈ $49.3m |
| NURIX THERAPEUTICS INC NRIX · 13G · filed 2026-08-14 | 7.5%≈ $187.7m |
| CENTURY THERAPEUTICS INC IPSC · 13G · filed 2026-01-15 | 7.3%≈ $33.0m |
| ACLARIS THERAPEUTICS INC ACRS · 13G · filed 2026-03-17 | 7.0%≈ $49.4m |
| AVALO THERAPEUTICS INC AVTX · 13G · filed 2026-08-14 | 6.9%≈ $66.7m |
| MIND MEDICINE MINDMED INC 13G · filed 2025-11-14 | 6.9% |
| ENGENE HOLDINGS INC 13G · filed 2025-11-18 | 6.7% |
| BICARA THERAPEUTICS INC BCAX · 13G · filed 2026-05-15 | 6.2%≈ $120.6m |
| ALUMIS INC ALMS · 13G · filed 2026-04-07 | 6.0%≈ $207.2m |
| STRUCTURE THERAPEUTICS INC GPCR · 13G · filed 2026-02-13 | 6.0% |